We are live on ! Find out more
BIO.B icon

Bio-Rad Laboratories Class B
BIO.B

6 hedge funds and large institutions have $1.11M invested in Bio-Rad Laboratories Class B in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $935K → $1.11M (+$172K)

0% less ownership

Funds ownership: 0.07%0.07% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

25% less funds holding

Funds holding: 86 (-2)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CL
1
CSS LLC
Illinois
$499K -$36.3K -115 -7%
Focus Partners Wealth
2
Focus Partners Wealth
Massachusetts
$251K +$240K +760 New
Morgan Stanley
3
Morgan Stanley
New York
$235K
Wells Fargo
4
Wells Fargo
California
$55.5K
WT
5
Whittier Trust
California
$53.6K
Jones Financial Companies
6
Jones Financial Companies
Missouri
$12.7K +$1.58K +5 +15%
JFA
7
JNBA Financial Advisors
Minnesota
-$534 -2 Closed
MG
8
Mather Group
Illinois
-$341 -1 Closed

BIO.B Hedge Fund Activity: Q3 2024 in Review

6 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2024, worth a combined $1.11M — up 18% from $935K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BIO.B and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Focus Partners Wealth, opening a new position worth an estimated $240K. The largest seller was CSS LLC, cutting an estimated $36.3K.

  • 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2024, down from 8 in Q2 2024.
  • Funds reported $1.11M of Bio-Rad Laboratories Class B stock for Q3 2024, up 18% quarter-over-quarter.
  • 1 fund opened new Bio-Rad Laboratories Class B positions in Q3 2024 and 2 closed out, a net change of -1 holder.
  • The largest Bio-Rad Laboratories Class B buyer in Q3 2024 was Focus Partners Wealth, an estimated $240K added.
  • The largest Bio-Rad Laboratories Class B seller in Q3 2024 was CSS LLC, an estimated $36.3K sold.

Based on aggregated 13F filings for Q3 2024.